Transdermal Therapeutics, Inc.
483 response sent September 23, 2014 · Birmingham, Alabama
- Inspection
- Jun 23 – Jun 27, 2014
- Investigator
- Claire M. Minden
- Pages
- 5
- FEI number
- 3010813678
In short: This is Transdermal Therapeutics, Inc.'s written response to FDA, dated September 23, 2014, for its site in Birmingham, Alabama (FEI 3010813678). It sets out the corrective actions the firm committed to.
Inside this response
This inspection in context
Claire M. Minden
26 documents · 2013–2022
Cites 211.42 (design and construction features) more than any other section. Most of their documents are for sites in Louisiana.
The firmTransdermal Therapeutics, Inc. history
The site's inspection history, in date order.
Similar documentsMore 483 responses
Browse other documents of this type.
Questions about this response
Who inspected Transdermal Therapeutics, Inc.?
Claire M. Minden is named on this 483 response, for the inspection of Jun 23 – Jun 27, 2014. Each investigator has a profile showing what they cite most.
When was Transdermal Therapeutics, Inc. inspected by FDA?
The inspection ran Jun 23 – Jun 27, 2014, and the 483 response is dated September 23, 2014.
How do I get the full 483 response for Transdermal Therapeutics, Inc.?
Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.